Resveratrol improves diabetic kidney disease by modulating the gut microbiota-short chain fatty acids axis in db/db mice

References

• Cai T-T, Ye X-L, Li R-R, Chen H, Wang Y-Y, Yong H-J, Pan M-L, Lu W, Tang Y, Miao H, et al. 2020. Resveratrol modulates the gut microbiota and inflammation to protect against diabetic nephropathy in mice. Front Pharmacol. 11:1249. doi: 10.3389/fphar.2020.01249.
   PubMed Web of Science ®Google Scholar
• Cameron KO, Kung DW, Kalgutkar AS, Kurumbail RG, Miller R, Salatto CT, Ward J, Withka JM, Bhattacharya SK, Boehm M, et al. 2016. Discovery and preclinical characterization of 6-chloro-5-[4-(1-hydroxycyclobutyl)phenyl]-1H-indole-3-carboxylic acid (PF-06409577), a direct activator of adenosine monophosphate-activated protein kinase (AMPK), for the potential treatment of diabetic nephropathy. J Med Chem. 59(17):8068–8081. doi: 10.1021/acs.jmedchem.6b00866.
   PubMed Web of Science ®Google Scholar
• Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, Fierer N, Peña AG, Goodrich JK, Gordon JI, et al. 2010. QIIME allows analysis of high-throughput community sequencing data. Nat Methods. 7(5):335–336. doi: 10.1038/nmeth.f.303.
   PubMed Web of Science ®Google Scholar
• Carmody RN, Gerber GK, Luevano JM, Jr., Gatti DM, Somes L, Svenson KL, Turnbaugh PJ. 2015. Diet dominates host genotype in shaping the murine gut microbiota. Cell Host Microbe. 17(1):72–84. doi: 10.1016/j.chom.2014.11.010.
   PubMed Web of Science ®Google Scholar
• Chen W, Bushinsky DA. 2018. Addressing racial disparity in the progression of chronic kidney disease: prescribe more fruits and vegetables? Am J Nephrol. 47(3):171–173. doi: 10.1159/000487716.
   PubMed Web of Science ®Google Scholar
• Chen X, Han Y, Gao P, Yang M, Xiao L, Xiong X, Zhao H, Tang C, Chen G, Zhu X, et al. 2019. Disulfide-bond a oxidoreductase-like protein protects against ectopic fat deposition and lipid-related kidney damage in diabetic nephropathy. Kidney Int. 95(4):880–895. doi: 10.1016/j.kint.2018.10.038.
   PubMed Web of Science ®Google Scholar
• Chen Z, Radjabzadeh D, Chen L, Kurilshikov A, Kavousi M, Ahmadizar F, Ikram MA, Uitterlinden AG, Zhernakova A, Fu J, et al. 2021. Association of insulin resistance and type 2 diabetes with gut microbial diversity: a microbiome-wide analysis from population studies. JAMA Netw Open. 14(7):e2118811. doi: 10.1001/jamanetworkopen.2021.18811.
   PubMed Web of Science ®Google Scholar
• David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, Ling AV, Devlin AS, Varma Y, Fischbach MA, et al. 2014. Diet rapidly and reproducibly alters the human gut microbiome. Nature. 505(7484):559–563. doi: 10.1038/nature12820.
   PubMed Web of Science ®Google Scholar
• Den Hartogh DJ, Tsiani E. 2019. Health benefits of resveratrol in kidney disease: evidence from in vitro and in vivo studies. Nutrients. 11(7):1624. doi: 10.3390/nu11071624.
   PubMed Web of Science ®Google Scholar
• Gowd V, Kang Q, Wang Q, Wang Q, Chen F, Cheng KW. 2020. Resveratrol: evidence for its nephroprotective effect in diabetic nephropathy. Adv Nutr. 11(6):1555–1568. doi: 10.1093/advances/nmaa075.
   PubMed Web of Science ®Google Scholar
• Hu ZB, Lu J, Chen PP, Lu CC, Zhang JX, Li XQ, Yuan BY, Huang SJ, Ruan XZ, Liu BC, et al. 2020. Dysbiosis of intestinal microbiota mediates tubulointerstitial injury in diabetic nephropathy via the disruption of cholesterol homeostasis. Theranostics. 10(6):2803–2816. doi: 10.7150/thno.40571.
   PubMed Web of Science ®Google Scholar
• Huang Y, Wang Z, Ye B, Ma JH, Ji S, Sheng W, Ye S, Ou Y, Peng Y, Yang X, et al. 2023. Sodium butyrate ameliorates diabetic retinopathy in mice via the regulation of gut microbiota and related short-chain fatty acids. J Transl Med. 21(1):451. doi: 10.1186/s12967-023-04259-4.
   PubMed Web of Science ®Google Scholar
• Hui S, Liu Y, Huang L, Zheng L, Zhou M, Lang H, Wang X, Yi L, Mi M. 2020. Resveratrol enhances brown adipose tissue activity and white adipose tissue browning in part by regulating bile acid metabolism via gut microbiota remodeling. Int J Obes (Lond). 44(8):1678–1690. doi: 10.1038/s41366-020-0566-y.
   PubMed Web of Science ®Google Scholar
• Kitada M, Kume S, Imaizumi N, Koya D. 2011. Resveratrol improves oxidative stress and protects against diabetic nephropathy through normalization of Mn-SOD dysfunction in AMPK/SIRT1-independent pathway. Diabetes. 60(2):634–643. doi: 10.2337/db10-0386.
   PubMed Web of Science ®Google Scholar
• Kumari A, Sodum N, Ravichandiran V, Kumar N. 2023. Role of SIRT-1 as a target for treatment and prevention of diabetic nephropathy: a review. Curr Mol Pharmacol. 16(8):811–831. doi: 10.2174/1874467216666230109140134.
   PubMed Web of Science ®Google Scholar
• Kuo Y-W, Huang Y-Y, Tsai S-Y, Wang J-Y, Lin J-H, Syu Z-J, Wang H-S, Hsu Y-C, Chen J-F, Hsia K-C, et al. 2023. Probiotic formula ameliorates renal dysfunction indicators, glycemic levels, and blood pressure in a diabetic nephropathy mouse model. Nutrients. 15(12):2803. doi: 10.3390/nu15122803.
   PubMed Web of Science ®Google Scholar
• Lei L, Zhang F, Huang J, Yang X, Zhou X, Yan H, Chen C, Zheng S, Si L, Jose PA, et al. 2023. Selenium deficiency causes hypertension by increasing renal AT(1) receptor expression via GPx1/H(2)O(2)/NF-κB pathway. Free Radic Biol Med. 200:59–72. doi: 10.1016/j.freeradbiomed.2023.02.021.
   PubMed Web of Science ®Google Scholar
• Li YJ, Chen X, Kwan TK, Loh YW, Singer J, Liu Y, Ma J, Tan J, Macia L, Mackay CR, et al. 2020. Dietary fiber protects against diabetic nephropathy through short-chain fatty acid-mediated activation of G protein-coupled receptors GPR43 and GPR109A. J Am Soc Nephrol. 31(6):1267–1281. doi: 10.1681/asn.2019101029.
   PubMed Web of Science ®Google Scholar
• Li C, Li L, Yang M, Yang J, Zhao C, Han Y, Zhao H, Jiang N, Wei L, Xiao Y, et al. 2022. PACS-2 ameliorates tubular injury by facilitating endoplasmic reticulum-mitochondria contact and mitophagy in diabetic nephropathy. Diabetes. 71(5):1034–1050. doi: 10.2337/db21-0983.
   PubMed Web of Science ®Google Scholar
• Li YJ, Ma J, Loh YW, Chadban SJ, Wu H. 2023. Short-chain fatty acids directly exert anti-inflammatory responses in podocytes and tubular epithelial cells exposed to high glucose. Front Cell Dev Biol. 11:1182570. doi: 10.3389/fcell.2023.1182570.
   PubMed Web of Science ®Google Scholar
• Li H, Zhao X, Zheng L, Wang X, Lin S, Shen J, Ren H, Li Y, Qiu Q, Wang Z. 2022. Bruceine A protects against diabetic kidney disease via inhibiting galectin-1. Kidney Int. 102(3):521–535. doi: 10.1016/j.kint.2022.04.020.
   PubMed Web of Science ®Google Scholar
• Macena MdL, Nunes LFdS, da Silva AF, Pureza IROM, Praxedes DRS, Santos JCdF, Bueno NB. 2022. Effects of dietary polyphenols in the glycemic, renal, inflammatory, and oxidative stress biomarkers in diabetic nephropathy: a systematic review with meta-analysis of randomized controlled trials. Nutr Rev. 80(12):2237–2259. doi: 10.1093/nutrit/nuac035.
   PubMed Web of Science ®Google Scholar
• Parks DH, Beiko RG. 2010. Identifying biologically relevant differences between metagenomic communities. Bioinformatics. 1526(6):715–721. doi: 10.1093/bioinformatics/btq041.
   PubMed Web of Science ®Google Scholar
• Recharla N, Geesala R, Shi XZ. 2023. Gut microbial metabolite butyrate and its therapeutic role in inflammatory bowel disease: a literature review. Nutrients. 15(10):2275. doi: 10.3390/nu15102275.
   PubMed Web of Science ®Google Scholar
• Schloss PD, Westcott SL, Ryabin T, Hall JR, Hartmann M, Hollister EB, Lesniewski RA, Oakley BB, Parks DH, Robinson CJ, et al. 2009. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol. 75(23):7537–7541. doi: 10.1128/AEM.01541-09.
   PubMed Web of Science ®Google Scholar
• Su M, Zhao W, Xu S, Weng J. 2022. Resveratrol in treating diabetes and its cardiovascular complications: a review of its mechanisms of action. Antioxidants (Basel). 11(6):1085. doi: 10.3390/antiox11061085.
   Google Scholar
• Tang G, Du Y, Guan H, Jia J, Zhu N, Shi Y, Rong S, Yuan W. 2022. Butyrate ameliorates skeletal muscle atrophy in diabetic nephropathy by enhancing gut barrier function and FFA2-mediated PI3K/Akt/mTOR signals. Br J Pharmacol. 179(1):159–178. doi: 10.1111/bph.15693.
   PubMed Web of Science ®Google Scholar
• Toba K, Hosojima M, Kabasawa H, Kuwahara S, Murayama T, Yamamoto-Kabasawa K, Kaseda R, Wada E, Watanabe R, Tanabe N, et al. 2019. Higher estimated net endogenous acid production with lower intake of fruits and vegetables based on a dietary survey is associated with the progression of chronic kidney disease. BMC Nephrol. 20(1):421. doi: 10.1186/s12882-019-1591-8.
   PubMed Web of Science ®Google Scholar
• Wang J, Tang H, Zhang C, Zhao Y, Derrien M, Rocher E, van-Hylckama. Vlieg JE, Strissel K, Zhao L, Obin M, et al. 2015. Modulation of gut microbiota during probiotic-mediated attenuation of metabolic syndrome in high fat diet-fed mice. ISME J. 9(1):1–15. doi: 10.1038/ismej.2014.99.
   PubMed Web of Science ®Google Scholar
• Wang XX, Wang D, Luo Y, Myakala K, Dobrinskikh E, Rosenberg AZ, Levi J, Kopp JB, Field A, Hill A, et al. 2018. FXR/TGR5 dual agonist prevents progression of nephropathy in diabetes and obesity. J Am Soc Nephrol. 29(1):118–137. doi: 10.1681/asn.2017020222.
   PubMed Web of Science ®Google Scholar
• Wu I-W, Gao S-S, Chou H-C, Yang H-Y, Chang L-C, Kuo Y-L, Dinh MCV, Chung W-H, Yang C-W, Lai H-C, et al. 2020. Integrative metagenomic and metabolomic analyses reveal severity-specific signatures of gut microbiota in chronic kidney disease. Theranostics. 10(12):5398–5411. doi: 10.7150/thno.41725.
   PubMed Web of Science ®Google Scholar
• Wu Z, Huang S, Li T, Li N, Han D, Zhang B, Xu ZZ, Zhang S, Pang J, Wang S, et al. 2021. Gut microbiota from green tea polyphenol-dosed mice improves intestinal epithelial homeostasis and ameliorates experimental colitis. Microbiome. 9(1):184. doi: 10.1186/s40168-021-01115-9.
   PubMed Web of Science ®Google Scholar
• Wu L, Liu C, Chang D-Y, Zhan R, Sun J, Cui S-H, Eddy S, Nair V, Tanner E, Brosius FC, et al. 2021. Annexin A1 alleviates kidney injury by promoting the resolution of inflammation in diabetic nephropathy. Kidney Int. 100(1):107–121. doi: 10.1016/j.kint.2021.02.025.
   PubMed Web of Science ®Google Scholar
• Yang M, Zhao L, Gao P, Zhu X, Han Y, Chen X, Li L, Xiao Y, Wei L, Li C, et al. 2019. DsbA-L ameliorates high glucose induced tubular damage through maintaining MAM integrity. EBioMedicine. 43:607–619. doi: 10.1016/j.ebiom.2019.04.044.
   PubMed Web of Science ®Google Scholar
• Zagato E, Pozzi C, Bertocchi A, Schioppa T, Saccheri F, Guglietta S, Fosso B, Melocchi L, Nizzoli G, Troisi J, et al. 2020. Endogenous murine microbiota member Faecalibaculum rodentium and its human homologue protect from intestinal tumour growth. Nat Microbiol. 5(3):511–524. doi: 10.1038/s41564-019-0649-5.
   PubMed Web of Science ®Google Scholar
• Zhang F, Lei L, Huang J, Wang W, Su Q, Yan H, Chen C, Zheng S, Ren H, Li Z, et al. 2022. G-protein-coupled receptor kinase 4 causes renal angiotensin II type 2 receptor dysfunction by increasing its phosphorylation. Clin Sci (Lond). 136(12):989–1003. doi: 10.1042/cs20220236.
   PubMed Web of Science ®Google Scholar
• Zhang B, Zhang Y, Liu X, Yin J, Li X, Zhang X, Xing X, Wang J, Wang S. 2022. Differential protective effect of resveratrol and its microbial metabolites on intestinal barrier dysfunction is mediated by the AMPK pathway. J Agric Food Chem. 70(36):11301–11313. doi: 10.1021/acs.jafc.2c04101.
   PubMedGoogle Scholar
• Zhu N, Duan H, Feng Y, Xu W, Shen J, Wang K, Liu J. 2023. Magnesium lithospermate B ameliorates diabetic nephropathy by suppressing the uremic toxin formation mediated by gut microbiota. Eur J Pharmacol. 953:175812. doi: 10.1016/j.ejphar.2023.175812.
   PubMed Web of Science ®Google Scholar